Official UK procurement notice
NCA30963 GMP Mangafodipir · UK public procurement notice
Authority: University Of Edinburgh (Education)
What is being bought
Published requirement descriptionFormulation and Good Manufacturing Practice preparation of mangafodipir for clinical use in healthy volunteers and patients.
CPV: Reagents and contrast media
The lotProcurement structure
single lot · no lot value publishedLot #1Under Regulation Reg 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015,…Awarded
Under Regulation Reg 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015, a contracting authority may use the negotiated procedure without the prior publication in the case of a public contract, based on the following justification:
- Competition is absent for technical reasons (only if it is not caused by artificial narrowing down of the parameters of the procurement and no reasonable alternative or substitute exists);
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 10 Aug 2021, 08:55 BST
- Last source update
- 10 Aug 2021, 08:55 BST
- Authority reference
NCA30963- FTS notice number
2021/S 000-019269- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02d2b4Find a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
- Published justification
For the last 2 years, we have been trying to source further preparations of the mangafodipir. This has included a global search for suppliers which has been unsuccessful. We are working with a Norwegian company to provide the product but has proved unsuccessful although future supplies may be possible in 1-2 years’ time. However, we have ongoing clinical trials and need a supply as soon as possible. We have now engaged with Avomeen (Element) who have previous experience with working with the product: this is quite unique with no other supplier having this experience. The product is rather complex to manufacture and formulate and given that they are the only current provider to generate the product and have the expertise, we have gone back to them. They seem to be the only company able to deal with the complexity of manufacture. The other issue is availability. The world’s supply and capacity for sterile fill products is severely stretched due to the massive global demand for SARS-CoV2 vaccines. We have worked with Element to try alternative sterile fill premises but there is no capacity in other facilities for the immediate future.
Publisher note: (SC Ref:662323)
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Avomeen | US$84,995 † | — | Awarded |
Contracts
Contract 019269-2021-NCA30963-1 · Avomeen
- Signed
- 29 Jul 2021
- Value
- US$84,995
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids · 0 electronic · 1 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Edinburgh Sheriff Court & Justice of the Peace CourtReview body
Bidders & participating suppliers
1 commercial party on the notice- AvomeenAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.